Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without Albuminuria.
Vistisen D, Andersen GS, Hulman A, Persson F, Rossing P, Jørgensen ME.
Diabetes Care. 2019 Oct;42(10):1886-1894.
http://doi.org/10.2337/dc19-0349
Epub 2019 Jun 20.
Recurrent diabetic ketoacidosis and a brief history of brittle diabetes research: contemporary and past evidence in diabetic ketoacidosis research including mortality, mental health and prevention.
Garrett CJ, Choudhary P, Amiel SA, Fonagy P, Ismail K.
Diabet Med. 2019 Nov;36(11):1329-1335.
http://doi.org/10.1111/dme.14109
Epub 2019 Aug 29.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
McMurray JJV1, Solomon SD1, et al.; DAPA-HF Trial Committees and Investigators.
N Engl J Med. 2019 Sep 19.
http://doi.org/10.1056/NEJMoa1911303
Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK.
Bain SC, Bakhai A, Evans M, Green A, Menown I, Strain WD.
Diabet Med. 2019 Sep;36(9):1063-1071.
http://doi.org/10.1111/dme.14058
Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.
RISE Consortium.
Diabetes Care. 2019 Sep;42(9):1742-1751.
http://doi.org/10.2337/dc19-0556
Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK.
Bain SC, Bakhai A, Evans M, Green A, Menown I, Strain WD.
Diabet Med. 2019 Sep;36(9):1063-1071.
http://doi.org/10.1111/dme.14058
Comentarios recientes